Clinical Trial Update: A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating Flonoltinib Maleate for intermediate- or high-risk myelofibrosis. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Flonoltinib Maleate (Flonoltinib maleate)

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: MF | Phase 3 | Status: RECRUITING